IP Impact on Funding - Perspectives from the Field Castel Commercialization of Academic Research Key Considerations in Securing Funding Early Stage Collaborative.

Slides:



Advertisements
Similar presentations
Go-to-Market Strategy
Advertisements

Knowledge intensive companies, IC readiness and Seed Capital New and Improved Activities, Outreach and Support Programs on IP Financing WIPO Forum on intellectual.
1. Introduction 2. Funding Instruments 3. Public Funding 4. Support from Banks 5. Private Equity Investment 6. Venture Capital 2.
IP Issues in Research Jim Baker, Executive Director Innovation, and Industry Engagement.
Principal Patent Analyst
© 2009 Getting the Investors’ Attention... And Secure Funding! 1.
Wisconsin Science and Technology Symposium Angel Investments July 18, 2008 Pete Marsnik Manager, Chippewa Valley Angel Investors Network, LLC
EXPRESS LICENSE AGREEMENTS Ted Hagelin Crandall Melvin Professor of Law Kauffman Professor of Entrepreneurship and Innovation Director, NY Science & Technology.
Golden Horseshoe Bioscience Network – Solutions for Life Golden Horseshoe Biosciences Network – Solutions for Life Darlene Homonko, PhD Executive Director.
Entrepreneurship I Class #3 Financing the Venture.
Enabling R&D collaborations from an SME perspective Pierre Meloche Federal Partners in Technology Transfer June
Talent First: opportunity to collaborate with Federal Labs Tony Bailetti Director, Talent First Director, Technology Innovation Management program (
Writing a Winning Business Plan. A business plan is a strategy for creating, launching and managing a new venture. It answers the questions of A business.
James Hogan Paul McLellan DAC Is this a system or chaos? Aggregate: “… the properties of components sum to the whole ”
Venture Capital Slide Show Presentation Suggested Format No more than 10 slides (not all slides No more than 10 slides (not all slides shown here will.
Business Plans For The Real World Barry Williams Delaware SBDC.
Writing a Winning Business Plan
Managing the Technology Transfer and Commercialization Process Best thing since sliced bread.
Presented by: TBIN, Inc. The Business & Investment Network busnetwk.com (631)
Vilnius Lithuania BSc.: Biochemistry Neuropsychology J.D.: University of Oregon LL.M.:University College London Pacific Northwest National Laboratory.
Flinders Technologies Pty Ltd Copyright © 2002 J V Turner WIPO/INV/BEI/02/7.a Universities and R&D organizations are potential sources of valuable intellectual.
KICKSTART SEED FUND: IGNITING INNOVATION KICKSTART SEED FUND OVERVIEW GAVIN CHRISTENSEN, MANAGING DIRECTOR, KICKSTART SEED FUND Aug, 2009.
Jacek Błoński Poznań, January 22, 2008 Business Angels as alternative source of financing early-stage investments.
GATEWAY TO FINNISH EXPERTISE 1 Commercialization guidelines – NanoCom and ProNano results Dr. Eeva Viinikka, Business Director Programme Director of National.
KIC InnoEnergy SE - CC Poland Plus Business Creation KIC InnoEnergy Highway Krakow, 12 April 2011.
Vcapital Confidential1 Startup Workshop Presentation to.
Photo by hernandezfisher - Creative Commons Attribution-NonCommercial-ShareAlike License with Haiku.
Chad Barden Financing Options for Entrepreneurs. Discussion Overview Available Options Venture Capital Private Equity (Angels) Grants Strategic Partners.
Finance Wales Investing in life sciences. Who are we?  The Finance Wales Group comprises:  Finance Wales  FW Capital, our non Welsh fund management.
Ready, Set, Grow Invest in your business and plan for growth.
Page 1 New Models for Commercialization Federal Partners in Technology Transfer June 18, 2009 A presentation by: Tom Corr Chief Executive Officer Accelerator.
Integrating Innovation
Industrial Innovations & Partnerships Small Business Innovation Research Opportunities National Science Foundation One Day Colloquium for U.S. – Greece.
© PEP 2005 All rights reserved “Connecting the Dots… from Researcher to Market” Harvesting the value of innovation Courtney Price, Ph.D.
Dr Caroline Barelle MBA Giving birth to a biotech where’s the pain relief ?!
1. Outline Financing Innovation Policy The Instruments Some Results Israel & Bulgaria Compared Conclusions for Bulgaria 2.
Industrial Innovations & Partnerships Juan E. Figueroa Program Director National Science Foundation Industrial Innovation and Partnerships Small Business.
NovusFolium Venture Partners Bridging Innovation to Markets Prospective Investment Opportunity.
Venture Capital Analysis Prof. Dell, Spring 2011.
1. 2 Who We Are – North Texas RCIC Connecting Innovation & Capital Our mission... to accelerate the growth of the North Texas technology based economy.
1 Company Name (Presenter’s name) Phone # Tag line.
A possible Intellectual Assets acquisition initiative for 4TU Proposal.
JUMPSTART NEW JERSEY ANGEL NETWORK Presentation at Pathway to Equity Financing Conference by Wayne Tamarelli, PhD Held by New Jersey.
Jacek Błoński Warsaw, April 22, 2008 Business Angels as alternative source of financing early-stage investments.
ONTARIO CENTRES OF EXCELLENCE Briefing for the York Boot Camp July 19, 2012.
Springboard Network Over 60 campuses in the region, many with active R&D. 16 campuses are in major cities.
Financing High Growth Ventures ETP Courage: Risk and the Dimensions of Work Life Cycle of a Business Venture Bootstrapping Self, Friends and Family.
Building Linkages & Picking Winners A Government Lab Perspective Mike Walker Commercialization Branch, NRC FPTT Annual Meeting Halifax 2004 A Government.
University Licensing Dominique Kleyn 27 th June 2003.
© 2004 Altira Group LLC. All Rights Reserved. Jim Newell Partner.
Enabling Building Efficiency: The NYC Urban Technology Innovation Center TIMOTHY CROSS, COLUMBIA ENGINEERING IEEE INNOVATION DAY POLYTECHNIC INSTITUTE.
Technology Transfer Office
Atlantic Bridge Dr Helen McBreen, INVESTMENT DIRECTOR
[Project Title] [Presentation Date]
Five Steps To Effective Research Proposals
65 Questions Venture Capitalists Will Ask of Startups
…. the Angel Perspective
Universities and the Commercial World
Diffusion Capital Partners
Venture Capital Slide Show Presentation
Startup Financing Greg Adolphe-Nazaire Dalhousie University
Where Economic Development Meets Venture Capital: Impact Investing
Funding a Start-up Venture
Angel Investing 201 Stages of investing Why a Portfolio?
Registration No. Contact Details of Applicant Startup Pitch Deck
Application and Presentation to the
Innovative Foundations Services.
Accessing Capital in Small Communities
Accredited investors investing in early stage companies
Accredited investors investing in early stage companies
Presentation transcript:

IP Impact on Funding - Perspectives from the Field Castel Commercialization of Academic Research Key Considerations in Securing Funding Early Stage Collaborative Research Primary concern is project can lead to economic impact Science and engineering advancement Novelty - has it been done before? disruptive vs incremental Develop / cultivate HQP Early Stage Commercialization Customer pull or Technology push Market opportunity & value proposition Technology differentiation & competitive advantage Ability to attract on-going investment Late Stage Commercialization License transfer Start-up Patents, Source Code, Trade Secrets and Know-how are the primary focus of IP portfolio Commercialization of Academic Research Key Considerations in Securing Funding Early Stage Collaborative Research Primary concern is project can lead to economic impact Science and engineering advancement Novelty - has it been done before? disruptive vs incremental Develop / cultivate HQP Early Stage Commercialization Customer pull or Technology push Market opportunity & value proposition Technology differentiation & competitive advantage Ability to attract on-going investment Late Stage Commercialization License transfer Start-up Patents, Source Code, Trade Secrets and Know-how are the primary focus of IP portfolio

IP Impact on Funding - Perspectives from the Field Castel Typical Academic Tech Funding Roadmap Basic Research - Discovery NSERC Institution, Canada Research Chairs, donations, endow, etc. Collaborative Research: NSERC, NCE, ISTP MRI, OCE, Industry Institution Pre-Commercialization: MRI - OCE Market Readiness, ORCP, C4, etc. NSERC i2i Institution (WIF, Tech Transfer depts, etc.) Friends & Family, Innovation Networks, NFPs, Foundations Commercialization Seed: MRI IAF, IDF, NCE-CCR EDC, BDC, NRC-IRAP, Precarn Angel, OCIF, Venture Capital Typical Academic Tech Funding Roadmap Basic Research - Discovery NSERC Institution, Canada Research Chairs, donations, endow, etc. Collaborative Research: NSERC, NCE, ISTP MRI, OCE, Industry Institution Pre-Commercialization: MRI - OCE Market Readiness, ORCP, C4, etc. NSERC i2i Institution (WIF, Tech Transfer depts, etc.) Friends & Family, Innovation Networks, NFPs, Foundations Commercialization Seed: MRI IAF, IDF, NCE-CCR EDC, BDC, NRC-IRAP, Precarn Angel, OCIF, Venture Capital

IP Impact on Funding - Perspectives from the Field Castel Typical Patent Roadmap (Commercialization Stages) Provisional Customer discovery Engage potential channel partners and investors Minimize cash burn PCT Buys time for learning and discovery through customer engagement while technology and commercialization plans are validated and mature Minimize cash burn Utility Ready for “Round A” financing Customer development and product launch Maintenance Company building Typical Patent Roadmap (Commercialization Stages) Provisional Customer discovery Engage potential channel partners and investors Minimize cash burn PCT Buys time for learning and discovery through customer engagement while technology and commercialization plans are validated and mature Minimize cash burn Utility Ready for “Round A” financing Customer development and product launch Maintenance Company building

IP Impact on Funding - Perspectives from the Field Castel Impact of IP on Obtaining Research Funding Institution (Uni or College) Varies widely with Institution and PI Different for Basic Research -> Commercial exploitation Often a prerequisite to take on as commercialization project Mostly fund IP filings Government Important in commercialization stage Often fund (Provisional) IP filings Industry Participation 3d party IP rights often a deterrent to due to cost, complexity, time to market Market opportunity and ability to exploit technology are prime Investor Valuation & Capital appreciation key (de-risk investment, create barriers to entry, develop IP assets) Mostly a pre-requisite Impact of IP on Obtaining Research Funding Institution (Uni or College) Varies widely with Institution and PI Different for Basic Research -> Commercial exploitation Often a prerequisite to take on as commercialization project Mostly fund IP filings Government Important in commercialization stage Often fund (Provisional) IP filings Industry Participation 3d party IP rights often a deterrent to due to cost, complexity, time to market Market opportunity and ability to exploit technology are prime Investor Valuation & Capital appreciation key (de-risk investment, create barriers to entry, develop IP assets) Mostly a pre-requisite

IP Impact on Funding - Perspectives from the Field Castel Survey: IP Impact on Research Academic Generally preferred to have IP (to $ supplement salary) but often with limited means to commercially exploit it. Time sensitive: Shelf-life of technology is ~3 years Royalty stream reduces cost of research (lowers overhead) Obligation to make a disclosure can be deal breaker Industry Mostly a barrier to collaboration due to future cost, complexity, time to market, publication requirement, etc. SME create IP for competitive advantage, to build beach head (niche), R&D cost recovery, capital appreciation. Large Corp more likely to acquire IP as needed than to create it. IP mining occurs. Discourages communication w/ PI Investor Qs: Technology, Customer, Pain, How Make $, Competition, Risk (IP), Team, $ Needed & Use, Time, Exit Mostly a requirement for funding Survey: IP Impact on Research Academic Generally preferred to have IP (to $ supplement salary) but often with limited means to commercially exploit it. Time sensitive: Shelf-life of technology is ~3 years Royalty stream reduces cost of research (lowers overhead) Obligation to make a disclosure can be deal breaker Industry Mostly a barrier to collaboration due to future cost, complexity, time to market, publication requirement, etc. SME create IP for competitive advantage, to build beach head (niche), R&D cost recovery, capital appreciation. Large Corp more likely to acquire IP as needed than to create it. IP mining occurs. Discourages communication w/ PI Investor Qs: Technology, Customer, Pain, How Make $, Competition, Risk (IP), Team, $ Needed & Use, Time, Exit Mostly a requirement for funding